Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Spicer

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2026
A subgroup analysis of perioperative pembrolizumab in clinical stage II non-small-cell lung cancer from the randomized keynote-671 studyMasahiro Tsuboi, Heather Wakelee, Marina C Garassino, et al.
Journal for Immunotherapy of Cancer|February 1, 2023
Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunityMark Sorin, Elham Karimi, Morteza Rezanejad, et al.
Lancet (London, England)|September 17, 2024
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trialJonathan D Spicer, Marina C Garassino, Heather Wakelee, et al.
Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.
Clinical Lung Cancer|February 20, 2024
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology NetworkYohann Pilon, Merav Rokah, Joseph Seitlinger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 20, 2024
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung CancerJonathan D Spicer, Tina Cascone, Murry W Wynes, et al.
The Journal of Experimental Medicine|April 18, 2020
Targeting potential drivers of COVID-19: Neutrophil extracellular trapsBetsy J Barnes, Jose M Adrover, Amelia Baxter-Stoltzfus, et al.
Cancer Research|January 26, 2024
Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in CancerXianbing Zhu, Zheng Fu, Kendall Dutchak, et al.
The Annals of Thoracic Surgery|October 30, 2025
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?Joseph Seitlinger, Olivier Salko, Luciano Bulgarelli Maqueda, et al.
Nature|February 1, 2023
Single-cell spatial landscapes of the lung tumour immune microenvironmentMark Sorin, Morteza Rezanejad, Elham Karimi, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2026
A subgroup analysis of perioperative pembrolizumab in clinical stage II non-small-cell lung cancer from the randomized keynote-671 studyMasahiro Tsuboi, Heather Wakelee, Marina C Garassino, et al.
Journal for Immunotherapy of Cancer|February 1, 2023
Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunityMark Sorin, Elham Karimi, Morteza Rezanejad, et al.
Lancet (London, England)|September 17, 2024
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trialJonathan D Spicer, Marina C Garassino, Heather Wakelee, et al.
Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.
Clinical Lung Cancer|February 20, 2024
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology NetworkYohann Pilon, Merav Rokah, Joseph Seitlinger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 20, 2024
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung CancerJonathan D Spicer, Tina Cascone, Murry W Wynes, et al.
The Journal of Experimental Medicine|April 18, 2020
Targeting potential drivers of COVID-19: Neutrophil extracellular trapsBetsy J Barnes, Jose M Adrover, Amelia Baxter-Stoltzfus, et al.
Cancer Research|January 26, 2024
Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in CancerXianbing Zhu, Zheng Fu, Kendall Dutchak, et al.
The Annals of Thoracic Surgery|October 30, 2025
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?Joseph Seitlinger, Olivier Salko, Luciano Bulgarelli Maqueda, et al.
Nature|February 1, 2023
Single-cell spatial landscapes of the lung tumour immune microenvironmentMark Sorin, Morteza Rezanejad, Elham Karimi, et al.
Pageof 8